文献速递结核与非结核分枝杆菌医院感染防控

成功背后的隐患:南非「治疗成功」结核病患者中次优治疗参与度的性别差异模式

Hidden in Success: Gendered Patterns of Suboptimal Care Engagement Among Tuberculosis Patients Who "Successfully" Completed Treatment in South Africa.
PubMed 文献 · Clin Infect Dis · 2026-01-01

本研究利用548名达到规划性治疗成功的结核病患者的药物补充数据,通过潜类别混合模型识别出3种纵向治疗参与轨迹:持续参与(84.1%)、2个月后次优参与(7.7%)和从起始即次优参与(8.2%)。完成治疗时,三类轨迹累计漏补充天数分别为9.7、68.4和55.5天。性别分层显示男性呈现全部3种轨迹,女性仅呈现持续参与和从起始即次优参与两种轨迹。既往结核史和HIV阴性状态与男性次优轨迹相关,既往结核史与女性次优参与相关。

要点

  • 规划性「治疗成功」掩盖了药物补充模式的异质性,约16%患者存在次优参与轨迹。
  • 男性呈现3种轨迹而女性仅2种,性别分层分析显示不同风险因素模式。
  • 既往结核史与男性和女性的次优参与均相关,男性HIV阴性状态与从起始即次优轨迹相关。

核心结论

  • 规划性「治疗成功」掩盖了结核病患者药物补充模式的异质性,需关注次优治疗参与轨迹。
  • 次优参与轨迹存在性别差异,需以患者为中心的咨询和性别响应性干预。
  • 缩短疗程本身可能无法解决次优参与问题,需要灵活的治疗策略。

研究设计与样本

  • 利用患者层面药物补充数据的纵向研究,采用潜类别混合模型识别治疗参与轨迹。
  • 纳入548名达到规划性治疗成功的结核病患者。
  • 采用逻辑回归分析与轨迹类别相关的参与者层面特征。

主要发现

  • 识别出3种轨迹:持续参与84.1%、2个月后次优参与7.7%、从起始即次优参与8.2%。
  • 完成治疗时三类轨迹累计漏补充天数分别为9.7(95%CI 7.4-11.8)、68.4(60.4-76.9)和55.5(48.1-62.7)天。
  • 男性呈现全部3种轨迹(83.1%、7.4%、9.5%),累计漏补充天数分别为10.6(7.8-13.3)、61.0(50.2-71.3)和62.31(53.14-71.72)天。
  • 女性仅呈现持续参与和从起始即次优参与两种轨迹(89.5%和10.5%),累计漏补充天数分别为12.1(7.8-16.5)和46.9(33.3-61.6)天。
  • 男性中既往结核史与2个月后次优参与(aOR 7.44,2.79-19.8)和从起始即次优参与(aOR 2.78,1.07-7.25)相关,HIV阴性状态与从起始即次优参与相关(aOR 2.72,1.13-6.54);女性中既往结核史与次优参与相关(aOR 5.22,1.11-24.44)。

临床怎么用

  • 对结核病「治疗成功」患者不应仅依赖规划性结局,需关注药物补充行为等次优参与指标。
  • 针对男性与女性分别识别次优参与风险因素,实施性别响应性干预。
  • 考虑灵活的治疗策略而非仅缩短疗程,以解决次优治疗参与问题。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Timeously completing tuberculosis (TB) treatment is a key to optimal health outcomes. Suboptimal treatment refill patterns, even among those categorized as "treatment success," may portend unfavorable outcomes. METHODS: Using patient-level medication refill data, latent-class mixed modeling was used to identify longitudinal trajectories of care engagement among TB patients achieving programmatic treatment success. Logistic regression was conducted to investigate participant-level characteristics associated with trajectory class membership. RESULTS: Among 548 participants, we identified 3 trajectories: Class 1 (consistent engagement; 84.1%), Class 2 (suboptimal engagement after 2 months; 7.7%), and Class 3 (suboptimal engagement from initiation; 8.2%). At treatment completion, Classes 1-3 accumulated 9.7 (95% confidence interval [CI]: 7.4-11.8), 68.4 (60.4-76.9), and 55.5 (48.1-62.7) missed refill days, respectively. In gender-stratified models, men exhibited all 3 trajectories (83.1%, 7.4%, and 9.5%, respectively), and accumulated 10.6 (7.8-13.3), 61.0 (50.2-71.3), and 62.31 (53.14-71.72) missed refill days, respectively. Women exhibited only Classes 1 and 3 (89.5% and 10.5%, respectively) and accumulated 12.1 (7.8-16.5) and 46.9 (33.3-61.6) missed refill days, respectively. Among men, prior TB (Class 2: adjusted odds ratio [aOR] 7.44, 2.79-19.8; Class 3: aOR 2.78, 1.07-7.25) and human immunodeficiency virus-negative status (Class 3: aOR 2.72, 1.13-6.54) were associated with suboptimal trajectories. Among women, prior TB was associated with suboptimal engagement (aOR 5.22, 1.11-24.44). CONCLUSIONS: Programmatic "treatment success" obscured heterogeneity in treatment refill patterns. Patient-centered counseling and gender-responsive interventions are needed to address treatment refill behaviors. Shorter regimens alone may not resolve suboptimal engagement, highlighting the need for flexible treatment strategies.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Medina-Marino A, Arua E, de Vos L, et al. Hidden in Success: Gendered Patterns of Suboptimal Care Engagement Among Tuberculosis Patients Who "Successfully" Completed Treatment in South Africa. Clin Infect Dis. 2026. PMID: 41417651. doi:10.1093/cid/ciaf714

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。